Luis-Esteban Tamariz-Amador

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Luis-Esteban Tamariz-Amador

Sep 24, 2024, 12:41 | Insight

Myeloma Paper of the Day, September 24th, suggested by Robert Orlowski

Robert Orlowski shared on X: “Myeloma Paper of the Day: Pre-clinical in vitro data suggest CD38/CD3xCD28…

Jul 27, 2024, 13:23 | Insight

Myeloma Paper of the Day, July 27th, suggested by Robert Orlowski

Robert Orlowski shared on X: "Myeloma Paper of the Day: Study of molecular mechanisms promoting long-term…

Jul 11, 2024, 14:47 | Insight

Flow cytometry to predict when to offer boosters to patients with multiple myeloma

Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Bruno Paiva, Director Flow…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023